Dear AuntMinnieEurope Member,
It's been a packed year for the medical imaging community, and as 2017 draws to a close, there are few signs the pace of change is about to slow down.
The Norwegians have published fresh information about their national breast screening program. The results suggest more frequent screening may be advisable for women with false-positive findings. Go to the Women's Imaging Community, or click here.
The process of pulling some gadolinium-based contrast agents (GBCAs) from the market is underway in Europe. U.K. regulators have ordered the withdrawal of two linear gadolinium agents by February. The move implements a ruling by the European Medicines Agency, which has told member states they have a year to withdraw several linear GBCAs from the market due to concerns about gadolinium retention. Learn more about the U.K. action by clicking here.
In cases of malignant melanoma, cardiac metastases occur increasingly often and can involve every part of the heart, so developing awareness of different types of metastases and their appearance on CT is essential, researchers from Tübingen, Germany, said. The group has elaborated on this topic with a new study. To get the findings, click here.
Another German group is convinced PET/MRI can be a valuable alternative for whole-body staging of patients with suspected recurrent pelvic cancer because the hybrid modality can detect markedly more malignant lesions than MRI alone. It's also superior in the distinction of intrapelvic recurrence versus distant metastatic spread. Visit the Molecular Imaging Community, or click here.
Meanwhile, it's all change at European Radiology. Incoming Editor-in-Chief Dr. Yves Menu has spoken about his plans and priorities for the journal in 2018. Click here to learn more.
On behalf of everybody at AuntMinnieEurope.com, I wish you all the very best for the festive season. We will be continuing to post new articles, so please do check our home page whenever you can. Also, next week we'll be revealing our top 10 stories for 2017.